Related Experiment Video
Updated: Mar 31, 2026
08:11
Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells
Published on: August 7, 2021
4.7K
Measurement of ADAMTS13
1Division of Hematology, Albert Einstein College of Medicine and Montefiore Medical Center, USA.
International Review of Thrombosis
|October 20, 2015
Summary
ADAMTS13 enzyme deficiency causes thrombotic thrombocytopenic purpura (TTP). This review clarifies the diagnostic role of ADAMTS13 assays in TTP, addressing persistent controversies and proposing improvements.
Area of Science:
- Biochemistry
- Genetics
- Hematology
Background:
- ADAMTS13 is a metalloprotease cleaving von Willebrand factor (VWF).
- ADAMTS13 deficiency leads to thrombotic thrombocytopenic purpura (TTP).
- Acquired TTP involves inhibitory antibodies, while hereditary TTP results from gene mutations.
Purpose of the Study:
- To review contentious issues surrounding ADAMTS13 assays in TTP diagnosis.
- To propose strategies for enhancing the diagnostic utility of ADAMTS13 testing.
Main Methods:
- Review of existing literature on ADAMTS13 and TTP.
- Analysis of the role of ADAMTS13 assays in TTP diagnosis.
Main Results:
- Controversies persist regarding the interpretation and application of ADAMTS13 assay results.
- ADAMTS13 assays are crucial for differentiating TTP subtypes and guiding treatment.
Conclusions:
- Improved standardization and understanding of ADAMTS13 assays are needed.
- Enhanced diagnostic protocols incorporating ADAMTS13 testing can improve TTP patient outcomes.
